review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Trevor J. Orchard | Q30223717 |
Ecosse L Lamoureux | Q75156305 | ||
Sheila K. West | Q85241581 | ||
Paul Mitchell | Q96121027 | ||
Hugh R. Taylor | Q37393483 | ||
James M Tielsch | Q40261966 | ||
Massimo Porta | Q43273739 | ||
Ronald Klein | Q44045637 | ||
Jakob Grauslund | Q56761243 | ||
Steven M. Haffner | Q64431345 | ||
Richard F. Hamman | Q64454798 | ||
P2093 | author name string | Jacqueline M Dekker | |
Barbara E K Klein | |||
Jie Jin Wang | |||
Jonathan Shaw | |||
Tien Y Wong | |||
Xinzhi Zhang | |||
Liang Xu | |||
M Kamran Ikram | |||
Rohit Varma | |||
Toke Bek | |||
Sannapaneni Krishnaiah | |||
Ningli Wang | |||
Ryo Kawasaki | |||
Takamasa Kayama | |||
Tarun Sharma | |||
Jonathan W Kowalski | |||
Astrid Fletcher | |||
Shih-Jen Chen | |||
Sophie L Rogers | |||
Miho Yasuda | |||
Korapat Mayurasakorn | |||
Mohan Rema | |||
Joseph P O'Hare | |||
Monique S Roy | |||
Joanne W Y Yau | |||
Meta-Analysis for Eye Disease (META-EYE) Study Group | |||
P2860 | cites work | The role of genetics in susceptibility to diabetic retinopathy | Q24651324 |
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
Global estimates of the prevalence of diabetes for 2010 and 2030 | Q29547218 | ||
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Q29622926 | ||
Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project | Q31793083 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema | Q70741925 | ||
3. Sampling variance of standardized mortality rates | Q72938359 | ||
Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factors | Q73356592 | ||
Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER | Q74086486 | ||
Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study | Q32098483 | ||
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. | Q33305306 | ||
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
Prevalence of diabetic retinopathy in the United States, 2005-2008. | Q34154127 | ||
The prevalence of and factors associated with diabetic retinopathy in the Australian population | Q34199750 | ||
Diabetic retinopathy in a multi-ethnic cohort in the United States | Q36464921 | ||
Overview of epidemiologic studies of diabetic retinopathy | Q36951796 | ||
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis | Q37437199 | ||
Prevalence of diabetes among men and women in China | Q39605920 | ||
The prevalence of diabetic retinopathy among adults in the United States | Q40517905 | ||
Diabetic retinopathy in Mexican Americans and non-Hispanic whites | Q44037303 | ||
Prevalence of diabetic retinopathy in rural China: the Handan Eye Study | Q46148180 | ||
Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study | Q46515278 | ||
Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. | Q46568353 | ||
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States | Q46749381 | ||
Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment | Q46893482 | ||
Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study | Q46930900 | ||
Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? | Q47274305 | ||
Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM. | Q51053891 | ||
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. | Q53619110 | ||
The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus | Q67756835 | ||
Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy | Q67957877 | ||
Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study | Q69749970 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years | Q70330511 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years | Q70330516 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diabetic retinopathy | Q631361 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 556-564 | |
P577 | publication date | 2012-02-01 | |
2012-03-01 | |||
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Global prevalence and major risk factors of diabetic retinopathy | |
P478 | volume | 35 |
Q50861252 | 1,25-Dihydroxyvitamin D3 Deficiency is Involved in the Pathogenesis of Diabetic Retinopathy in the Uygur Population of China. |
Q94461905 | A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study) |
Q38677861 | A Comprehensive Study of Retinal Vessel Classification Methods in Fundus Images |
Q59796439 | A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury |
Q42684832 | A Diabetic Retinopathy Screening Tool for Low-Income Adults in Mexico |
Q37202995 | A Meta-Analysis of Association between Methylenetetrahydrofolate Reductase Gene (MTHFR) 677C/T Polymorphism and Diabetic Retinopathy |
Q94453419 | A New Approach for Diabetic Macular Edema Treatment: review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes |
Q58597926 | A Novel Vision-Enhancing Technology for Low-Vision Impairments |
Q64900527 | A Protocol to Evaluate Retinal Vascular Response Using Optical Coherence Tomography Angiography. |
Q37731896 | A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study |
Q89965756 | A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy |
Q34985146 | A Web-based interactive diabetes registry for health care management and planning in Saudi Arabia |
Q37485876 | A bibliometric analysis of academic publication on diabetic retinopathy disease trends during 1980-2014: a global and medical view |
Q54130366 | A clinical correlation of conjunctival microangiopathy with grades of retinopathy in type 2 diabetes mellitus. |
Q100750415 | A cross-sectional study on diabetes epidemiology among people aged 40 years and above in Shenyang, China |
Q55384382 | A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. |
Q47230436 | A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema |
Q34510550 | A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. |
Q35592903 | A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series |
Q36872704 | A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy |
Q39089813 | A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression |
Q64101207 | A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand |
Q57157493 | A review of the multifunctionality of angiopoietin-like 4 in eye disease |
Q27008325 | A review of therapies for diabetic macular oedema and rationale for combination therapy |
Q37405425 | A simple integrated primary health care based model for detection of diabetic retinopathy in resource-limited settings in Pakistani population |
Q37444532 | A study on the association of diabetic dermopathy with nephropathy and retinopathy in patients with type 2 diabetes mellitus |
Q58718911 | A super-resolution method-based pipeline for fundus fluorescein angiography imaging |
Q38175406 | Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases |
Q92738470 | Accumulation of advanced glycation end products potentiate human retinal capillary endothelial cells mediated diabetic retinopathy |
Q33817379 | Accuracy and reliability of retinal photo grading for diabetic retinopathy: Remote graders from a developing country and standard retinal photo grader in Australia |
Q92642592 | Accuracy of the smartphone-based nonmydriatic retinal camera in the detection of sight-threatening diabetic retinopathy |
Q39141199 | Acircularity index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls measured by optical coherence tomography angiography |
Q55447099 | Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema. |
Q35962947 | Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review |
Q41998002 | Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents |
Q92534563 | Adults visual impairment and blindness - An overview of prevalence and causes in Saudi Arabia |
Q58557619 | Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review |
Q38088818 | Advances in our understanding of diabetic retinopathy. |
Q36766212 | Advances in retinal imaging for diabetic retinopathy and diabetic macular edema |
Q60929999 | Advancing Health Disparities Research in Population Health |
Q53704361 | Aflibercept in Diabetic Macular Oedema Previously Refractory to Standard Intravitreal Therapy: An Irish Retrospective Study. |
Q27334828 | African Ancestry Analysis and Admixture Genetic Mapping for Proliferative Diabetic Retinopathy in African Americans |
Q35116153 | Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese |
Q98945457 | Altered Intrinsic Brain Activities in Patients with Diabetic Retinopathy Using Amplitude of Low-frequency Fluctuation: A Resting-state fMRI Study |
Q37542643 | An Automated Detection System for Microaneurysms That Is Effective across Different Racial Groups |
Q41973311 | An In Silico Approach towards the Prediction of Druglikeness Properties of Inhibitors of Plasminogen Activator Inhibitor1. |
Q49993165 | An overview of the clinical outcomes of the fluocinolone acetonide 190 µg intravitreal implant clinical evidence study in the United Kingdom (ICE-UK). |
Q55021084 | Analysis of Changes in Retinal Thickness in Type 2 Diabetes without Diabetic Retinopathy. |
Q57493143 | Analysis of Foveal Microvascular Abnormalities in Diabetic Retinopathy Using Optical Coherence Tomography Angiography with Projection Artifact Removal |
Q89579353 | Analysis of association between common variants of uncoupling proteins genes and diabetic retinopathy in a Chinese population |
Q89663550 | Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study |
Q93172776 | Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats |
Q34251889 | Angiotensin II-related hypertension and eye diseases |
Q41504603 | Animal Models of Diabetic Retinopathy |
Q36959934 | Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics |
Q64083037 | Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema |
Q91842594 | Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice |
Q93384458 | Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema |
Q24187587 | Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema |
Q54115470 | Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. |
Q57456682 | Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis |
Q34558187 | Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. |
Q47147918 | Anti-vascular endothelial growth factor indications in ocular disease |
Q62089583 | Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy |
Q56775677 | Application of higher-order spectra for automated grading of diabetic maculopathy |
Q33773561 | Application of random forests methods to diabetic retinopathy classification analyses |
Q53490476 | Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy. |
Q51454835 | Aqueous humour concentrations of TGF-β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy. |
Q61446484 | Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China |
Q88007076 | Are light masks useful for early diabetic macular oedema? |
Q38451253 | Are reactive oxygen species still the basis for diabetic complications? |
Q92025402 | Arginine and Carnitine Metabolites Are Altered in Diabetic Retinopathy |
Q58553410 | Artificial intelligence and deep learning in ophthalmology |
Q93134057 | Artificial intelligence for diabetic retinopathy screening: a review |
Q104485906 | Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study |
Q104478923 | Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study |
Q92914581 | Artificial intelligence-based screening for diabetic retinopathy at community hospital |
Q36629520 | Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy |
Q48499144 | Assessment of Annual Diabetic Eye Examination Using Telemedicine Technology Among Underserved Patients in Primary Care Setting. |
Q33702923 | Assessment of macular function using the SKILL Card in adults with type 2 diabetes mellitus |
Q96684015 | Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis |
Q37533412 | Assessment of the Relationship between Diabetic Retinopathy and Nailfold Capillaries in Type 2 Diabetics with a Noninvasive Method: Nailfold Videocapillaroscopy |
Q92463409 | Associated risk factors in the early stage of diabetic retinopathy |
Q47215013 | Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes |
Q91898492 | Association between Hyperreflective Foci on Spectral-Domain Optical Coherence Tomography and Early Recurrence of Diabetic Macular Edema after Intravitreal Dexamethasone Implantation |
Q49827267 | Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema. |
Q57045583 | Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review |
Q42137930 | Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects |
Q47111812 | Association between the number of natural teeth and diabetic retinopathy among type 2 diabetes mellitus: The Korea national health and nutrition examination survey |
Q53267477 | Association of ARHGAP22 gene polymorphisms with the risk of type 2 diabetic retinopathy. |
Q36363393 | Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis |
Q91601723 | Association of FokI, TaqI, BsmI and ApaI polymorphisms with diabetic retinopathy: a pooled analysis of case-control studies |
Q55102286 | Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients. |
Q37504145 | Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT) |
Q90446393 | Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers |
Q57219568 | Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey |
Q41145559 | Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study |
Q34419106 | Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes |
Q36148134 | Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis |
Q35745320 | Association of retinopathy and intima media thickness of common carotid artery in type 2 diabetic patients |
Q41874907 | Association of serum lipids with diabetic retinopathy in type 2 diabetes |
Q64282639 | Association of the Serum Total Cholesterol to Triglyceride Ratio with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Community-Based Study |
Q54961322 | Associations between sleep duration, sleep quality and diabetic retinopathy. |
Q50098051 | Associations of Physical Activity and Sedentary Behaviour with Vision-Threatening Diabetic Retinopathy in Indonesian Population with Type 2 Diabetes Mellitus: Jogjakarta Eye Diabetic Study in the Community (JOGED.COM). |
Q64122411 | Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study |
Q55711848 | Astragaloside IV protects RGC-5 cells against oxidative stress. |
Q92370282 | Astragalus polysaccharide attenuates metabolic memory-triggered ER stress and apoptosis via regulation of miR-204/SIRT1 axis in retinal pigment epithelial cells |
Q55416398 | Automated Diagnosis and Grading of Diabetic Retinopathy Using Optical Coherence Tomography. |
Q47137147 | Automated detection of photoreceptor disruption in mild diabetic retinopathy on volumetric optical coherence tomography. |
Q50072679 | Automated segmentation of hyperreflective foci in spectral domain optical coherence tomography with diabetic retinopathy. |
Q99551232 | Automatic detection of non-perfusion areas in diabetic macular edema from fundus fluorescein angiography for decision making using deep learning |
Q36899665 | Automatic differentiation of color fundus images containing drusen or exudates using a contextual spatial pyramid approach |
Q92969312 | Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in primary health care in security forces hospital Riyadh, Saudi Arabia |
Q53695752 | Awareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia. |
Q64281576 | Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia |
Q39417384 | Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy |
Q92384173 | Barriers for Adherence to Diabetic Retinopathy Screening among Saudi Adults |
Q54988945 | Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema. |
Q41995332 | Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy |
Q54981625 | Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus. |
Q89567602 | Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study |
Q36092355 | Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer? |
Q33583030 | Biomarkers in Diabetic Retinopathy |
Q39223411 | Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy. |
Q42123271 | Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy. |
Q53413992 | Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy. |
Q37628516 | Body mass index and retinopathy in type 1 diabetic patients. |
Q33765398 | Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review |
Q37368103 | Body mass index: a risk factor for retinopathy in type 2 diabetic patients |
Q64330052 | Bone Marrow CD133 Stem Cells Ameliorate Visual Dysfunction in Streptozotocin-induced Diabetic Mice with Early Diabetic Retinopathy |
Q36988482 | Botanical compounds: effects on major eye diseases |
Q38613091 | Brain functional networks: correlation analysis with clinical indexes in patients with diabetic retinopathy |
Q60955477 | Burden of diabetic retinopathy in mainland China: Protocol for an updated systematic review and meta-analysis of prevalence and risk factors to identify prevention policies |
Q36622467 | C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus |
Q41459896 | CDKAL1 rs7756992 is associated with diabetic retinopathy in a Chinese population with type 2 diabetes. |
Q50205839 | Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes. |
Q38295438 | Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis |
Q64066763 | Can the appropriateness of eye care be measured through cross-sectional retrospective patient record review in eye care practices in Australia? The iCareTrack feasibility study |
Q35925938 | Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema |
Q36705336 | Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy |
Q104070102 | Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study |
Q92594584 | Central Macular Thickness in Diabetic Patients: A Sex-based Analysis |
Q26998699 | Challenges in elucidating the genetics of diabetic retinopathy |
Q91637896 | Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries |
Q36010448 | Changes in retinal microvascular diameter in patients with diabetes |
Q36156286 | Changes in the Macular Ganglion Cell Complex Thickness and Central Macular Thickness after Argon Laser Panretinal Photocoagulation |
Q37310218 | Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population |
Q37397066 | Changing Clinical Presentation, Current Knowledge-Attitude-Practice, and Current Vision Related Quality of Life in Self-Reported Type 2 Diabetes Patients with Retinopathy in Eastern India: The LVPEI Eye and Diabetes Study |
Q35717962 | Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy |
Q90397106 | Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia |
Q90413555 | Choroidal Thickness and Urinary Albumin Excretion in Type 2 Diabetic Patients without Retinopathy |
Q64986317 | Circular RNAs: Novel Promising Biomarkers in Ocular Diseases. |
Q26744760 | Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology |
Q90374530 | Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 3-year Pilot Study Evaluating Morpho-Functional Retinal Changes |
Q38994731 | Clinical Components of Telemedicine Programs for Diabetic Retinopathy |
Q37516050 | Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea. |
Q36222032 | Clinical Evaluation of Correlation Between Diabetic Retinopathy with Modifiable, Non-Modifiable and Other Independent Risk Factors in Tertiary Set-up in Central Rural India |
Q36379507 | Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects |
Q38608755 | Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes. |
Q35996718 | Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation |
Q33933846 | Clinical features of diabetic patients referred by general physicians due to less ophthalmic examinations |
Q36159029 | Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists |
Q33899234 | Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography |
Q34139793 | Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema |
Q53614209 | Combination of Bevacizumab and NGF Reduces the Risk of Diabetic Retinopathy. |
Q41528726 | Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema |
Q35195660 | Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats |
Q89241658 | Commentary on "Community care for diabetic retinopathy and glaucoma in India: A panel discussion" |
Q41144757 | Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes. |
Q90353204 | Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy |
Q33444386 | Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography |
Q36393864 | Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: the multicenter Brazilian Type 1 Diabetes Study |
Q37607065 | Comparison of Cysts in Red and Green Images for Diabetic Macular Edema |
Q55362259 | Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema. |
Q35722473 | Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema |
Q91842539 | Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis |
Q48316496 | Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema. |
Q41025677 | Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema |
Q92073684 | Computer aided diabetic retinopathy detection based on ophthalmic photography: a systematic review and Meta-analysis |
Q58094539 | Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection |
Q92112467 | Cone photoreceptor density in type I diabetic patients measured with an adaptive optics retinal camera |
Q98613395 | Conjunctival Microangiopathy in Diabetes Mellitus Assessed with Optical Coherence Tomography Angiography |
Q53766666 | Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism. |
Q58710225 | Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial |
Q41007892 | Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema |
Q64951612 | Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment. |
Q90004592 | Correlation of retinal vascular perfusion density with dark adaptation in diabetic retinopathy |
Q64092412 | Correlations among Diabetic Microvascular Complications: A Systematic Review and Meta-analysis |
Q92578847 | Correlations between visual acuity and macular microvasculature quantified with optical coherence tomography angiography in diabetic macular oedema |
Q34267270 | Corticosteroid use for diabetic macular edema: old fad or new trend? |
Q90220983 | Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review |
Q36095304 | Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up |
Q91563960 | Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema |
Q60913080 | Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies |
Q41678993 | Cost-utility analysis of screening for diabetic retinopathy in Japan: a probabilistic Markov modeling study |
Q59447403 | Curcumin Modulates DNA Methyltransferase Functions in a Cellular Model of Diabetic Retinopathy |
Q33447283 | Current and Next Generation Portable Screening Devices for Diabetic Retinopathy |
Q34750020 | Current concepts in diabetic retinopathy |
Q38010064 | Current epidemiology of diabetic retinopathy and diabetic macular edema |
Q59797373 | Current management of diabetic tractional retinal detachments |
Q55259517 | Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography. |
Q55382668 | Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy. |
Q92448282 | Deep and Densely Connected Networks for Classification of Diabetic Retinopathy |
Q91869666 | Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study |
Q90056412 | Deep learning-based single-shot prediction of differential effects of anti-VEGF treatment in patients with diabetic macular edema |
Q38749195 | Delayed follow-up in patients with diabetic retinopathy in South India: Social factors and impact on disease progression |
Q31155420 | Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials |
Q100307184 | Density-based classification in diabetic retinopathy through thickness of retinal layers from optical coherence tomography |
Q90635453 | Design, Development, and Evaluation of a Teleophthalmology System Using a Low-Cost Fundus Camera |
Q94551036 | Design, implementation, and evaluation of a nurse-led intravitreal injection programme for retinal diseases in Singapore |
Q92003034 | Detailed Evaluation of Possible Ganglion Cell Loss in the Retina of Zucker Diabetic Fatty (ZDF) Rats |
Q49199328 | Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment. |
Q97525481 | Detection of Diabetic Retinopathy Using Bichannel Convolutional Neural Network |
Q91967115 | Determinants of diabetic retinopathy in Southwest Ethiopia: a facility-based case-control study |
Q45942996 | Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. |
Q64257305 | Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy |
Q46249426 | Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome. |
Q92696069 | Dexamethasone implant in the management of diabetic macular edema from clinician's perspective |
Q50922705 | Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study. |
Q35828114 | Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. |
Q26799423 | Dexamethasone intravitreal implant in the treatment of diabetic macular edema |
Q47123458 | Diabetes and Diabetic Retinopathy: Knowledge, Attitude, Practice (KAP) among Diabetic Patients in A Tertiary Eye Care Centre |
Q35017752 | Diabetes and retinal vascular dysfunction |
Q93035199 | Diabetes care in the dispersed population of Greenland. A new model based on continued monitoring, analysis and adjustment of initiatives taken |
Q93014563 | Diabetes retinopathy and related health management in Asians versus whites using BRFSS 2005-2017 data |
Q64980448 | Diabetic Macular Edema: Is Your Patient Going Blind? |
Q94453474 | Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study |
Q95641816 | Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema |
Q37477129 | Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population |
Q36556183 | Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic |
Q28356500 | Diabetic Retinopathy Screening Using Telemedicine Tools: Pilot Study in Hungary |
Q48207622 | Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance |
Q28076765 | Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs |
Q92130384 | Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network |
Q92537532 | Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes |
Q34551730 | Diabetic Retinopathy: A Position Statement by the American Diabetes Association. |
Q58579972 | Diabetic Retinopathy: A complex pathophysiology requiring novel therapeutic strategies |
Q37494858 | Diabetic Retinopathy: Battling the Global Epidemic |
Q88657191 | Diabetic Retinopathy: Focus on Minority Populations |
Q38865568 | Diabetic brain or retina? Visual psychophysical performance in diabetic patients in relation to GABA levels in occipital cortex |
Q36766200 | Diabetic care initiatives to prevent blindness from diabetic retinopathy in India |
Q38816237 | Diabetic choroidopathy: a review of the current literature |
Q26830284 | Diabetic complications in obese type 2 diabetic rat models |
Q43109414 | Diabetic complications: current challenges and opportunities. |
Q59797366 | Diabetic macular edema: Evidence-based management |
Q33713517 | Diabetic macular edema: new concepts in patho-physiology and treatment |
Q36096676 | Diabetic macular oedema |
Q47310979 | Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines |
Q30234323 | Diabetic macular oedema: clinical risk factors and emerging genetic influences. |
Q30101045 | Diabetic macular oedema: evidence-based treatment recommendations for Asian countries. |
Q36018006 | Diabetic macular oedema: pathophysiology, management challenges and treatment resistance |
Q95578275 | Diabetic retinopathy |
Q55446891 | Diabetic retinopathy among Brazilian Xavante Indians. |
Q98464363 | Diabetic retinopathy among Omanis: Prevalence and clinical profile |
Q92964630 | Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy |
Q96172012 | Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group |
Q88611041 | Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus |
Q37346399 | Diabetic retinopathy and its risk factors at the university hospital in Jamaica. |
Q42193031 | Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study |
Q36555926 | Diabetic retinopathy and the associated risk factors in diabetes type 2 patients in Abha, Saudi Arabia |
Q89928675 | Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early? |
Q89928669 | Diabetic retinopathy screening and treatment in Myanmar: a pilot study |
Q55241071 | Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data. |
Q98947044 | Diabetic retinopathy screening in persons with mental illness: a literature review |
Q39451009 | Diabetic retinopathy: Breaking the barrier |
Q37703546 | Diabetic retinopathy: Knowledge, awareness and practices of physicians in primary-care centers in Riyadh, Saudi Arabia |
Q38365800 | Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option? |
Q39445950 | Diabetic retinopathy: current understanding, mechanisms, and treatment strategies |
Q38682902 | Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review |
Q49887766 | Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. |
Q35975239 | Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema |
Q38199730 | Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment |
Q39208422 | Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms. |
Q34498235 | Diabetic retinopathy: pathogenesis, clinical grading, management and future developments |
Q53832992 | Diabetics Retinopathy Knowledge and Awareness Assessment among the Type 2 Diabetics. |
Q38853204 | Diagnostic performance of retinal digital photography for diabetic retinopathy screening in primary care |
Q47330811 | Diet and risk of diabetic retinopathy: a systematic review |
Q36884076 | Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC). |
Q40303756 | Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. |
Q92102799 | Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review |
Q26470625 | Different lasers and techniques for proliferative diabetic retinopathy |
Q52653937 | Different lasers and techniques for proliferative diabetic retinopathy. |
Q55325329 | Differential effect of body mass index on the incidence of diabetes and diabetic retinopathy in two Asian populations. |
Q64104671 | Digital image processing software for diagnosing diabetic retinopathy from fundus photograph |
Q99212624 | Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective |
Q90950418 | Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture |
Q37321649 | Divergent Perceptions of Barriers to Diabetic Retinopathy Screening Among Patients and Care Providers, Los Angeles, California, 2014-2015. |
Q92701923 | Do Genomic Factors Play a Role in Diabetic Retinopathy? |
Q93013182 | Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective |
Q35669943 | Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a "Protective" Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients? |
Q40051233 | Does the 'slipping slipper sign' in patients with diabetes predict the presence of retinopathy and nephropathy? |
Q28074223 | Does tight control of systemic factors help in the management of diabetic retinopathy? |
Q48209586 | E2f1 mediates high glucose-induced neuronal death in cultured mouse retinal explants |
Q91693232 | Early Detection of Microvascular Changes in Patients with Diabetes Mellitus without and with Diabetic Retinopathy: Comparison between Different Swept-Source OCT-A Instruments |
Q42379751 | Early changes in retinal structure and BMP2 expression in the retina and crystalline lens of streptozotocin-induced diabetic pigs |
Q94038538 | Effect of Glucose on Retinal Endothelial Cell Viability and VEGF Secretion |
Q92642597 | Effect of health education and screening location on compliance with diabetic retinopathy screening in a rural population in Maharashtra |
Q64059372 | Effect of ripasudil on diabetic macular edema |
Q50220747 | Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats. |
Q90070733 | Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina |
Q94474862 | Effect of vitamin B12 supplementation on retinal lesions in diabetic rats |
Q93131685 | Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD) |
Q58809070 | Effectiveness of peer support to increase uptake of retinal examination for diabetic retinopathy: study protocol for the DURE pragmatic cluster randomized clinical trial in Kirinyaga, Kenya |
Q89002608 | Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema |
Q55270087 | Effects of Diets with Different Proportions of Protein/Carbohydrate on Retinal Manifestations in db Mice. |
Q90282553 | Effects of Hypertension, Diabetes, and Smoking on Age and Sex Prediction from Retinal Fundus Images |
Q35557492 | Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis |
Q85890421 | Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials |
Q41105960 | Effects of water drinking test on ocular blood flow waveform parameters: A laser speckle flowgraphy study |
Q36331293 | Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema |
Q36949135 | Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea. |
Q36088924 | Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study |
Q48213638 | Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol |
Q94476057 | Efficacy of switching therapy to aflibercept for patients with persistent diabetic macular edema: a systematic review and meta-analysis |
Q36021525 | Electronic Patient Records to Identify Patients in the United Kingdom with Diabetic Macular Oedema Suitable for ILUVIEN(®) (Fluocinolone Acetonide). |
Q58748857 | Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes |
Q38912512 | Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. |
Q38241679 | Emerging drugs for diabetic macular edema |
Q92859254 | Emerging therapies in the management of macular edema: a review |
Q40262807 | Enhanced Oxidative Stress and Other Potential Biomarkers for Retinopathy in Type 2 Diabetics: Beneficial Effects of the Nutraceutic Supplements |
Q98577923 | Ensemble Deep Learning for Diabetic Retinopathy Detection Using Optical Coherence Tomography Angiography |
Q27003941 | Epidemiological issues in diabetic retinopathy |
Q28074027 | Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998-2015: a systematic review and meta-analysis |
Q26775552 | Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss |
Q36648831 | Epigenetic Mechanisms of the Aging Human Retina |
Q37291255 | Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway |
Q36842815 | Estimating the proportion of persons with diabetes developing diabetic retinopathy in India: A systematic review and meta-analysis |
Q64285261 | Evaluating All Potential Oral Complications of Diabetes Mellitus |
Q97530407 | Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series |
Q33607767 | Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion |
Q64248194 | Evaluation of multiple risk factors involved in the development of Diabetic Retinopathy |
Q88692179 | Evaluation of optic disc, retinal nerve fiber and macular ganglion cell layers in pediatric diabetes |
Q53013320 | Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy. |
Q35171497 | Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema |
Q48021114 | Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes |
Q34889065 | Evidence underlying the clinical management of diabetic macular oedema. |
Q28075473 | Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines |
Q90197764 | Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life |
Q92410327 | Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice |
Q99635845 | Eye care utilization among diabetics in the South African National Health and Nutrition Examination Survey (SANHANES-1): a cross-sectional study |
Q28546854 | FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy |
Q91788680 | Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients |
Q91875398 | Factors associated with non-proliferative diabetic retinopathy in patients with type 1 and type 2 diabetes: the Japan Diabetes Complication and its Prevention prospective study (JDCP study 4) |
Q92265948 | Factors influencing clinical outcomes in patients with diabetic macular edema treated with intravitreal ranibizumab: comparison between responder and non-responder cases |
Q100559375 | Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy |
Q33684390 | Familial History of Diabetes is Associated with Poor Glycaemic Control in Type 2 Diabetics: A Cross-sectional Study |
Q97645328 | Feasibility of a cluster randomized controlled trial on the effectiveness of peer-led health education interventions to increase uptake of retinal examination for diabetic retinopathy in Kirinyaga, Kenya: a pilot trial |
Q95275220 | Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial |
Q47132940 | Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data. |
Q94596430 | Females with Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve-Province Cross-Sectional Study in China |
Q30248492 | Fenofibrate and Diabetic Retinopathy |
Q94340447 | Fenofibrate for diabetic retinopathy |
Q50446490 | Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity. |
Q28068032 | Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See? |
Q26852189 | Fluocinolone acetonide (ILUVIEN®) micro-implant for chronic diabetic macular edema |
Q34555355 | Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema |
Q34758061 | Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema |
Q41096571 | Follow-up of the retinal nerve fiber layer thickness of diabetic patients type 2, as a predisposing factor for glaucoma compared to normal subjects |
Q33914662 | Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study |
Q35140341 | Fully automatic segmentation of fluorescein leakage in subjects with diabetic macular edema |
Q51202732 | Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy. |
Q35935835 | Future opportunities in diabetic retinopathy research |
Q97567741 | Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update |
Q47757436 | Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study |
Q94600785 | Genetics of diabetes mellitus and diabetes complications |
Q35739097 | Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy |
Q55332045 | Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy. |
Q72435485 | Genome-wide association study for proliferative diabetic retinopathy in Africans |
Q92602572 | Global Assessment of Retinal Arteriolar, Venular and Capillary Microcirculations Using Fundus Photographs and Optical Coherence Tomography Angiography in Diabetic Retinopathy |
Q46638002 | Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis |
Q64070450 | Global prevalence of diabetic retinopathy: protocol for a systematic review and meta-analysis |
Q96225063 | Glucose fluctuations promote vascular BK channels dysfunction via PKCα/NF-κB/MuRF1 signaling |
Q38730387 | Glycated hemoglobin A1C and vitamin D and their association with diabetic retinopathy severity |
Q100515982 | Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis |
Q54990705 | Gonadal Hormones and Retinal Disorders: A Review. |
Q58087851 | Granular lesions of short-wavelength and near-infrared autofluorescence in diabetic macular oedema |
Q92642623 | Guidelines for the prevention and management of diabetic retinopathy and diabetic eye disease in India: A synopsis |
Q40364101 | HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics |
Q39364380 | Health-related quality of life of Finnish patients with diabetes |
Q37718835 | Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema |
Q64069710 | Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review |
Q50085138 | Hematopoietic stem/progenitor involvement in retinal microvascular repair during diabetes: Implications for bone marrow rejuvenation. |
Q35681309 | High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes. |
Q35870130 | High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico |
Q92131187 | How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments? |
Q94461782 | Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment |
Q38658492 | Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. |
Q90065220 | Hypertension, blood pressure control and diabetic retinopathy in a large population-based study |
Q39042956 | Hypertensive eye disease: a review. |
Q38614087 | Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy |
Q47104735 | IGF1 gene polymorphisms associated with diabetic retinopathy risk in Chinese Han population |
Q86561866 | Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis |
Q92771204 | Identification of novel differentially expressed genes in retinas of STZ-induced long-term diabetic rats through RNA sequencing |
Q31134280 | Identification of novel drug targets for the treatment of diabetic retinopathy |
Q64059815 | Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program |
Q35234189 | Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy. |
Q35892696 | Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy |
Q55201911 | Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies. |
Q99239952 | Impact of Socioeconomic Disadvantage and Diabetic Retinopathy Severity on Poor Ophthalmic Follow-Up in a Rural Vermont and New York Population |
Q36100154 | Impact of educational interventions in reducing diabetic complications: a systematic review |
Q53282743 | Impact of estimated glomerular filtration rate on diabetic macular edema. |
Q36955704 | Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion |
Q35007582 | Impact of insulin treatment in diabetic macular edema therapy in type 2 diabetes. |
Q39218792 | Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study |
Q33871462 | Improving Consensus Scoring of Crowdsourced Data Using the Rasch Model: Development and Refinement of a Diagnostic Instrument |
Q92298815 | Improving diabetic and hypertensive retinopathy with a medical food containing L-methylfolate: a preliminary report |
Q31050639 | Improving visual prognosis of the diabetic patients during the past 30 years based on the data of the Finnish Register of Visual Impairment |
Q36091590 | In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography |
Q57951352 | Incidence and progression of diabetic retinopathy within a private diabetes mellitus clinic in South Africa |
Q90058779 | Incidence and progression of diabetic retinopathy: a systematic review |
Q57922412 | Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study |
Q96680410 | Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents |
Q41122443 | Increased O-GlcNAcylation of NF-κB Enhances Retinal Ganglion Cell Death in Streptozotocin-induced Diabetic Retinopathy. |
Q30363053 | Increased Retinal Oxygen Metabolism Precedes Microvascular Alterations in Type 1 Diabetic Mice. |
Q37161442 | Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy |
Q49935713 | Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus. |
Q99583151 | Increased vitreal levels of interleukin-10 in diabetic retinopathy: a Meta-analysis |
Q93066925 | Indications and outcomes of vitrectomy surgery in a series of 1000 black African eyes |
Q38608819 | Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine. |
Q46081457 | Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema: A Post Hoc Analysis of the RIDE/RISE Trials |
Q47360842 | Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes |
Q48308519 | Influence of glycosylated hemoglobin on the choroidal thickness. |
Q64112936 | Inhibition of Aberrant IGF-I Signaling in Diabetic Male Rat Retina Prevents and Reverses Changes of Diabetic Retinopathy |
Q46165292 | Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy |
Q60912827 | Inhibition of stromal cell-derived factor-1α/CXCR4 signaling restores the blood-retina barrier in pericyte-deficient mouse retinas |
Q96685477 | Insights into the growing popularity of artificial intelligence in ophthalmology |
Q30718043 | Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy |
Q101237502 | Intensive treat-to-target statin therapy and severity of diabetic retinopathy complicated by hypercholesterolaemia |
Q90731596 | Internal fat mediates the impact of age on diabetes onset in chinese people between 30 and 44 years old |
Q24186687 | Interventions to increase attendance for diabetic retinopathy screening |
Q47559649 | Interventions to increase attendance for diabetic retinopathy screening. |
Q30681823 | Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy |
Q53511112 | Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial. |
Q92465248 | Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy |
Q49241521 | Intravitreal dexamethasone implants for diabetic macular edema. |
Q90578278 | Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review |
Q33814542 | Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes. |
Q37734051 | Inverse Association between Serum Bilirubin Levels and Retinopathy in Patients with Type 2 Diabetes Mellitus |
Q34655098 | Inverse association between high blood 25-hydroxyvitamin D levels and diabetic retinopathy in a representative Korean population |
Q35685140 | Investigating Factors Associated with Depression of Type 2 Diabetic Retinopathy Patients in China |
Q58762930 | Investigating the Fractal Dimension of the Foveal Microvasculature in Relation to the Morphology of the Foveal Avascular Zone and to the Macular Circulation in Patients With Type 2 Diabetes Mellitus |
Q34514392 | Investigation of variants in UCP2 in Chinese type 2 diabetes and diabetic retinopathy |
Q88796123 | Involvement of ciliary neurotrophic factor in early diabetic retinal neuropathy in streptozotocin-induced diabetic rats |
Q33614579 | Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study |
Q30372692 | Is fenofibrate a reasonable treatment for diabetic microvascular disease? |
Q57145910 | Is there a relationship between body mass index and diabetic retinopathy in type II diabetic patients? A cross sectional study |
Q40050054 | Is there any correlation between vitamin D insufficiency and diabetic retinopathy? |
Q39699517 | Kernel regression based segmentation of optical coherence tomography images with diabetic macular edema. |
Q38171217 | Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. |
Q89457085 | Knowledge and practices of fundoscopy among general practitioners in Qassim Province, Saudi Arabia, for the management of diabetic retinopathy and diabetic macular edema: A cross-sectional study |
Q92073661 | Knowledge and practices of primary care physicians on the current referral system of diabetic retinopathy in Islamabad and Rawal-Pindi, Pakistan |
Q94601616 | Large-Scale Neuronal Network Dysfunction in Diabetic Retinopathy |
Q26995365 | Laser, intravitreal drug application, and surgery to treat diabetic eye disease |
Q92150307 | Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study |
Q42378533 | LncRNAs: key players and novel insights into diabetes mellitus |
Q98178541 | Long-Term Tea Consumption Is Associated with Reduced Risk of Diabetic Retinopathy: A Cross-Sectional Survey among Elderly Chinese from Rural Communities |
Q26799531 | Long-term Outcomes in Youths with Diabetes Mellitus |
Q28292764 | Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema |
Q57920483 | Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study |
Q64907084 | Lycium Barbarum Polysaccharides Improve Retinopathy in Diabetic Sprague-Dawley Rats. |
Q52309509 | MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy. |
Q36613656 | Machine Learning Approaches for Detecting Diabetic Retinopathy from Clinical and Public Health Records |
Q38791673 | Machine Learning Methods to Predict Diabetes Complications. |
Q47978837 | Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes. |
Q89795782 | Macular Optical Coherence Tomography Angiography in Nephropathic Patients with Diabetic Retinopathy in Iran: A Prospective Case-Control Study |
Q35728048 | Macular ischemia and outcome of vitrectomy for diabetic macular edema |
Q87273692 | Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy |
Q92621245 | Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema |
Q35931863 | Magnitude and determinants of diabetic retinopathy among persons with diabetes registered at employee health department of a tertiary Eye Hospital of central Saudi Arabia |
Q38302499 | Male-female differences in diabetic retinopathy? |
Q48579709 | Management of diabetic macular edema in Japan: a review and expert opinion. |
Q38882106 | Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? |
Q40144050 | Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment |
Q60919942 | Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes |
Q33719419 | Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus |
Q55399207 | Metamorphopsia Score and Central Visual Field Outcomes in Diabetic Cystoid Macular Edema. |
Q28088750 | Methods and algorithms for optical coherence tomography-based angiography: a review and comparison |
Q91762118 | MicroRNAs as biomarkers of diabetic retinopathy and disease progression |
Q33603455 | Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction |
Q42362614 | Milestones in blindness prevention in India |
Q35666228 | Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira). |
Q33631921 | Minireview: Challenges and opportunities in development of PPAR agonists |
Q47113167 | Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes |
Q53270174 | Modeling long-term diabetes and related complications in rats. |
Q57183608 | Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets |
Q27014620 | Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets |
Q28078199 | Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy |
Q62477925 | Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control |
Q44618729 | Multifocal electroretinogram responses in Nepalese diabetic patients without retinopathy. |
Q35544948 | Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure |
Q47954026 | Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis. |
Q47911906 | NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression |
Q47094741 | NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes. |
Q43191572 | NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis. |
Q89529534 | NOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy |
Q30579323 | NRF2 plays a protective role in diabetic retinopathy in mice |
Q36396201 | Nanoparticle-motivated gene delivery for ophthalmic application |
Q35188001 | NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice |
Q38693846 | Naringin attenuates diabetic retinopathy by inhibiting inflammation, oxidative stress and NF-κB activation in vivo and in vitro |
Q36063335 | National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy |
Q90060268 | Network Pharmacology-based Investigation of the Underlying Mechanism of Panax Notoginseng Treatment of Diabetic Retinopathy |
Q90376643 | Neurodegeneration in diabetic retinopathy: does it really matter? |
Q26798351 | Neuroinflammatory responses in diabetic retinopathy |
Q92105332 | New Lipid Mediators in Retinal Angiogenesis and Retinopathy |
Q33583037 | New Therapeutic Approaches in Diabetic Retinopathy |
Q38710250 | New insights: A role for O-GlcNAcylation in diabetic complications |
Q55155684 | Non-Mydriatic Fundus Retinography in Screening for Diabetic Retinopathy: Agreement Between Family Physicians, General Ophthalmologists, and a Retinal Specialist. |
Q90455503 | Non-mydriatic fundus camera screening with diagnosis by telemedicine for diabetic retinopathy patients with type 1 and type 2 diabetes: a hospital-based cross-sectional study |
Q37204025 | Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review |
Q41717724 | Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes |
Q99585116 | Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema |
Q28066675 | Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon? |
Q49380314 | Novel therapeutic targets in diabetic macular edema: Beyond VEGF. |
Q50874501 | Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy. |
Q38094006 | Nuclear GAPDH: changing the fate of Müller cells in diabetes |
Q35970441 | O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells |
Q55208760 | Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections. |
Q35549983 | Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy |
Q50582610 | Optic disc detection in retinal fundus images using gravitational law-based edge detection. |
Q38987112 | Optical Coherence Tomography Angiography in Diabetes |
Q24186424 | Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy |
Q96954253 | Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review |
Q34693503 | Optimal treatment of diabetic retinopathy |
Q92152517 | Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia |
Q64882207 | Out of darkness comes light-is there a role for light masks in treatment of diabetic macular oedema? |
Q47095285 | Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema |
Q38480783 | Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. |
Q46248374 | Oxidative stress and reactive oxygen species: a review of their role in ocular disease |
Q38019841 | Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies |
Q35589517 | P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans |
Q96950447 | PPARα activation directly upregulates thrombomodulin in the diabetic retina |
Q64245243 | Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-A/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes |
Q48227262 | Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. |
Q60301928 | Pathological changes in the cellular structures of retina and choroidea in the early stages of alloxan-induced diabetes |
Q58591190 | Pathophysiology of Diabetic Retinopathy: The Old and the New |
Q47761979 | Patient Attitudes Toward Telemedicine for Diabetic Retinopathy. |
Q35230987 | Patient characteristics associated with measurement of routine diabetes care: an observational study |
Q92407666 | Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR |
Q37723748 | Pattern Visual Evoked Potential Changes in Diabetic Patients without Retinopathy. |
Q91598448 | Pattern and Presentation of Vitreo-Retinal Diseases: An Analysis of Retrospective Data at a Tertiary Eye Care Center in Nepal |
Q58778173 | Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan |
Q89167709 | Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging |
Q92187715 | Pericytes: Problems and Promises for CNS Repair |
Q39055178 | Periodontitis is associated with diabetic retinopathy in non-obese adults |
Q91062954 | Peripapillary microvasculature in patients with diabetes mellitus: An optical coherence tomography angiography study |
Q36318318 | Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema |
Q57035913 | Personalized risk-based screening for diabetic retinopathy: a multivariate approach vs. the use of stratification rules |
Q26786012 | Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema |
Q64058295 | Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy |
Q49384584 | Pharmacologic management of diabetic retinopathy. |
Q93006844 | Pharmacological Inhibition of Spermine Oxidase Reduces Neurodegeneration and Improves Retinal Function in Diabetic Mice |
Q36610531 | Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients. |
Q36608921 | Pilot study using mobile health to coordinate the diabetic patient, diabetologist, and ophthalmologist |
Q111822859 | Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy |
Q37093044 | Planning a programme to prevent visual loss from diabetic retinopathy |
Q36104687 | Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema |
Q51269699 | Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema. |
Q26859982 | Plasma kallikrein-kinin system and diabetic retinopathy |
Q51069605 | Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy. |
Q55364528 | Possible neuroprotective role of P2X2 in the retina of diabetic rats. |
Q48213393 | Potential beneficial effect of low-dose danazol in combination with renin-angiotensin system inhibitors in diabetic macular oedema. |
Q39126178 | Potential regulatory mechanisms of lncRNA in diabetes and its complications |
Q90695615 | Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery |
Q58129903 | Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms |
Q92399114 | Prediction of Proliferative Diabetic Retinopathy to Asymptomatic Obstructive Coronary Artery Disease in Chinese Type 2 Diabetes Individuals: An Exploratory Study |
Q93150629 | Predictive Models for Diabetic Retinopathy from Non-Image Teleretinal Screening Data |
Q33606076 | Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice. |
Q64268367 | Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab |
Q52938566 | Predictors of Photographic Quality with a Handheld Nonmydriatic Fundus Camera Used for Screening of Vision-Threatening Diabetic Retinopathy. |
Q47149927 | Predictors of uptake of eye examination in people living with diabetes mellitus in three counties of Kenya |
Q92998065 | Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye? |
Q93102470 | Presbyopia and Other Eye Conditions in Teachers in Ghana |
Q30244246 | Presence and Risk Factors for Glaucoma in Patients with Diabetes |
Q35663730 | Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study |
Q47167329 | Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study |
Q43087824 | Prevalence and associated factors of diabetic retinopathy in rural central India |
Q90579091 | Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes |
Q92767550 | Prevalence and causes of avoidable blindness and visual impairment, including the prevalence of diabetic retinopathy in Siwan district of Bihar, India: A population-based survey |
Q35502290 | Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia |
Q41328655 | Prevalence and causes of low vision and blindness in a Chinese population with type 2 diabetes: the Dongguan Eye Study. |
Q38199083 | Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. |
Q91917437 | Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study |
Q36295183 | Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study |
Q34992483 | Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey |
Q38818921 | Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark |
Q90148019 | Prevalence and risk factors for diabetic retinopathy in a cross-sectional population-based study from rural southern China: Dongguan Eye Study |
Q55006702 | Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: the Bhaktapur Retina Study. |
Q42052435 | Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies |
Q93118971 | Prevalence of Diabetes and Prediabetes in Adults from a Third-Tier City in Eastern China: A Cross-Sectional Study |
Q38387608 | Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure |
Q47155478 | Prevalence of Diabetic Retinopathy and its Associated Factors in a Rural Area of Villupuram District of Tamil Nadu, India |
Q40460731 | Prevalence of Diabetic Retinopathy in Urban Slums: The Aditya Jyot Diabetic Retinopathy in Urban Mumbai Slums Study-Report 2. |
Q34433671 | Prevalence of and risk factors for diabetic macular edema in the United States |
Q55445642 | Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives. |
Q42656602 | Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study. |
Q53080674 | Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study. |
Q33706116 | Prevalence of diabetic retinopathy in Iran: a systematic review and Meta-analysis |
Q55063040 | Prevalence of diabetic retinopathy in Pakistan; A systematic review. |
Q38075074 | Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries |
Q36374753 | Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain) |
Q39675641 | Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS). |
Q39148804 | Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. |
Q64244861 | Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis |
Q37595628 | Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa |
Q38995550 | Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors. |
Q34076715 | Prevalence of retinopathy among adults with self-reported diabetes mellitus: the Sri Lanka diabetes and Cardiovascular Study |
Q46965530 | Prevalence, Awareness and Determinants of Diabetic Retinopathy in a Screening Centre in Nigeria |
Q55262838 | Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: A cross-sectional study. |
Q37166969 | Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study |
Q30991231 | Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance |
Q90084589 | Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis |
Q55099824 | Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. |
Q92463074 | Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema |
Q28661253 | Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study |
Q33828636 | Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy |
Q61810069 | Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney) |
Q104485901 | Progress in examining cost-effectiveness of AI in diabetic retinopathy screening |
Q100430570 | Progress of artificial intelligence in diabetic retinopathy screening |
Q36369491 | Proliferative diabetic retinopathy: laser or eye injection? |
Q93181086 | Protection by vitamin D against high-glucose-induced damage in retinal pigment epithelial cells |
Q38654549 | Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction |
Q64907800 | Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy. |
Q36502289 | Protective effects of SIRT1 in patients with proliferative diabetic retinopathy via the inhibition of IL-17 expression |
Q64246319 | Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation |
Q90249496 | Protective roles of autophagy in retinal pigment epithelium under high glucose condition via regulating PINK1/Parkin pathway and BNIP3L |
Q89002577 | Psychophysical Exams as Early Indicators of Diabetic Retinopathy |
Q93223915 | Public health system integration of avoidable blindness screening and management, India |
Q58040299 | Pursuing type 1 diabetes mellitus and related complications through urinary proteomics |
Q39148545 | Putative protective role of lutein and zeaxanthin in diabetic retinopathy |
Q41034223 | Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography |
Q33741713 | Quality of Life in People with Diabetic Retinopathy: Indian Study |
Q48272704 | Quality of life, impaired vision and social role in people with diabetes: a multicenter observational study |
Q64241331 | Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography |
Q92727494 | Quantitative Microvascular Analysis With Wide-Field Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy |
Q59797551 | RF/6A Chorioretinal Cells Do Not Display Key Endothelial Phenotypes |
Q55316713 | Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema. |
Q36235336 | Rationale and Methodology for a Community-Based Study of Diabetic Retinopathy in an Indonesian Population with Type 2 Diabetes Mellitus: The Jogjakarta Eye Diabetic Study in the Community |
Q39307436 | Reaching the Unreachable: Novel Approaches to Telemedicine Screening of Underserved Populations for Vitreoretinal Disease |
Q92533148 | Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema |
Q37603037 | Real-Life ILUVIEN (Fluocinolone Acetonide) Case Study: Rapid Drying of the Macula and Improved Vision within 2 Years after Therapy Initiation |
Q94464949 | Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes |
Q58804239 | Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study |
Q89172339 | Real-life experience of ranibizumab for diabetic macular edema in Taiwan |
Q90751266 | Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources |
Q38671399 | Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario |
Q38665017 | Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom. |
Q90314995 | Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study |
Q64911569 | Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. |
Q38747087 | Recent Advancements in Retinal Vessel Segmentation. |
Q39079275 | Recent advances in molecular biomarkers for diabetes mellitus: a systematic review |
Q54956778 | Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. |
Q47096339 | Recurrent Diabetic Macular Edema: What to Do. |
Q53388406 | Reduced Amputation Rate by Circular TNP Application on Split-Skin Grafts After Deep Dermal Foot Scalds in Insulin-Dependent Diabetic Patients. |
Q51701226 | Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema. |
Q52560208 | Reduction of Endoplasmic Reticulum Stress Improves Angiogenic Progenitor Cell function in a Mouse Model of Type 1 Diabetes. |
Q37222342 | Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. |
Q55049881 | Regional differences in the prevalence of diabetic retinopathy: a multi center study in Brazil. |
Q33563100 | Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema |
Q26774344 | Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis |
Q35866161 | Relationship between Diabetic Retinopathy and Subclinical Hypothyroidism: a meta-analysis |
Q37045034 | Relationship between Functional and Structural Changes in Diabetic Vessels in Optical Coherence Tomography Angiography |
Q98290104 | Relationship between Serum Vascular Endothelial Growth Factor Levels and Stages of Diabetic Retinopathy and Other Biomarkers |
Q91559826 | Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea |
Q92471958 | Relationship between diabetic macular edema and choroidal layer thickness |
Q41571864 | Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland |
Q33585807 | Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway |
Q47928006 | Resting heart rate is associated with nonproliferative retinopathy in normoalbuminuric type 1 diabetic patients. |
Q39102573 | Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema |
Q41625930 | Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases |
Q92422679 | Retinal Blood Velocity and Flow in Early Diabetes and Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy |
Q38605095 | Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy |
Q36070169 | Retinal Image Enhancement Using Robust Inverse Diffusion Equation and Self-Similarity Filtering |
Q35910183 | Retinal Imaging Techniques for Diabetic Retinopathy Screening |
Q99561828 | Retinal Physiology and Circulation: Effect of Diabetes |
Q64937118 | Retinal Vasculature in Development and Diseases. |
Q58730421 | Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril |
Q90154071 | Retinal exams requested at Primary Care Unit: indications, results and alternative strategies of evaluation |
Q48260488 | Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA2 inhibitor Darapladib. |
Q90269763 | Retinal vasculature-function correlation in non-proliferative diabetic retinopathy |
Q91593821 | Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy |
Q47099578 | Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors. |
Q51015951 | Retinopathy with central oedema in an INS C94Y transgenic pig model of long-term diabetes. |
Q48416276 | Retinopathy, nephropathy, peripheral neuropathy and geriatric scale scores in elderly people with Type 2 diabetes. |
Q38673270 | Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015. |
Q42367664 | Reversible retinal vessel closure from VEGF-induced leukocyte plugging |
Q101476472 | Review of retinal cameras for global coverage of diabetic retinopathy screening |
Q55518628 | Review on the prevalence of diabetes and risk factors and situation of disease management in floating population in China. |
Q36853930 | Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes |
Q35803183 | Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection |
Q35692338 | Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database |
Q92106288 | Risk Factors of Thyroid Dysfunction in Patients With Type 2 Diabetes Mellitus |
Q58760646 | Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus |
Q54877898 | Risk factors for diabetic retinopathy: a case-control study. |
Q37275536 | Risk factors for the progression of intima-media thickness of carotid arteries: a 2-year follow-up study in patients with newly diagnosed type 2 diabetes |
Q37257978 | Risk factors of retinopathy in type 2 diabetes mellitus at a tertiary care hospital, Bahawalpur Pakistan |
Q42364223 | Role of Angiopoietins and Tie-2 in Diabetic Retinopathy |
Q92594491 | Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography |
Q35104388 | Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population. |
Q39238324 | Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy |
Q26775853 | Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant |
Q42330281 | Role of lipid-lowering agents in the management of diabetic retinopathy |
Q27016431 | Role of plasma kallikrein in diabetes and metabolism |
Q41891788 | Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration. |
Q37038437 | Scientometric Analysis and Mapping of Scientific Articles on Diabetic Retinopathy |
Q40502875 | Screening Intervals for Diabetic Retinopathy and Implications for Care |
Q34717944 | Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea |
Q42372185 | Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device |
Q89954644 | Screening for diabetic retinopathy: new perspectives and challenges |
Q50081277 | Screening for vision-threatening diabetic retinopathy in South India: comparing portable non-mydriatic and standard fundus cameras and clinical exam. |
Q38118778 | Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review |
Q42292862 | Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy |
Q47386296 | Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway. |
Q47879810 | Secretogranin III: a diabetic retinopathy-selective angiogenic factor. |
Q58608160 | Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery |
Q47409299 | Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy |
Q41695768 | Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy |
Q36241451 | Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes |
Q87145995 | Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage |
Q36832811 | Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients |
Q36992469 | Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes |
Q88542920 | Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps |
Q58782172 | Severity of diabetic retinopathy at the first ophthalmological examination in the Lebanese population |
Q64092868 | Sex Differences in the Prevalence, Awareness, Treatment, and Control of Diabetes Mellitus Among Adults Aged 45 Years and Older in Rural Areas of Northern China: A Cross-Sectional, Population-Based Study |
Q90427791 | Shared Care for Patients with Diabetes at Risk of Retinopathy: A Feasibility Trial |
Q90078739 | Short term effect of intravitreal bevacizumab for diabetic macular edema associated with epiretinal membrane |
Q90637855 | Single herbal medicine for diabetic retinopathy |
Q36842799 | Situational analysis of services for diabetes and diabetic retinopathy and evaluation of programs for the detection and treatment of diabetic retinopathy in India: Methods for the India 11-city 9-state study |
Q47831386 | Sleep and diabetic retinopathy. |
Q35111271 | Social deprivation as a risk factor for late presentation of proliferative diabetic retinopathy |
Q47115045 | Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal |
Q38195792 | Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives |
Q60947291 | Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications |
Q47117481 | Spectropathology-corroborated multimodal quantitative imaging biomarkers for neuroretinal degeneration in diabetic retinopathy |
Q92642568 | Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India |
Q92642566 | Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus |
Q42701686 | Specvis: Free and open-source software for visual field examination. |
Q41393449 | Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study. |
Q36638879 | Structural Changes by Spectral Domain Optical Coherence Tomography in Patients With Type 1 Diabetes Mellitus |
Q36357725 | Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period |
Q52979847 | Study methodology and diabetes control in patients from the non-English diabetes management project (NEDMP). |
Q35553181 | Study of 27 Aqueous Humor Cytokines in Type 2 Diabetic Patients with or without Macular Edema |
Q48277485 | Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography |
Q48099937 | Study of retinal neurodegeneration and maculopathy in diabetic Meriones shawi: A particular animal model with human-like macula. |
Q49827430 | Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature. |
Q91809852 | Sub-threshold micropulse laser treatment reduces inflammatory biomarkers in aqueous humour of diabetic patients with macular edema |
Q36848538 | Suitability of a Low-Cost, Handheld, Nonmydriatic Retinograph for Diabetic Retinopathy Diagnosis. |
Q92447094 | Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease |
Q47918653 | Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting |
Q89531841 | Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles |
Q63435749 | Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy |
Q47108753 | Switching to Aflibercept in Diabetic Macular Edema Not Responding to Ranibizumab and/or Intravitreal Dexamethasone Implant |
Q64067357 | Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs |
Q50021425 | Symmetry of peripheral retinal nonperfusion in diabetic retinopathy by ischemic index. |
Q49244967 | Synergistic interaction between prolonged increased glycemic exposure and mildly increased urinary albumin excretion on diabetic retinopathy. |
Q47701463 | Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery |
Q58603294 | Systematic review and meta-analysis of diagnostic accuracy of detection of any level of diabetic retinopathy using digital retinal imaging |
Q35231230 | Systematic review of various laser intervention strategies for proliferative diabetic retinopathy. |
Q40305170 | Systematic screening for diabetic retinopathy (DR) in Hong Kong: prevalence of DR and visual impairment among diabetic population. |
Q91842400 | Systemic Factors Associated with Treatment Response in Diabetic Macular Edema |
Q98163435 | Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus |
Q36123333 | Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease. |
Q35067111 | Systemic medical management of diabetic retinopathy |
Q36939054 | TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes |
Q90027408 | TRPV4 Channels as Therapeutic Targets in Diabetes and Diabetes-related Complications |
Q38990050 | Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema |
Q34275560 | Telemedicine and ocular health in diabetes mellitus |
Q27014047 | Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis |
Q38898370 | Telemedicine in diabetic retinopathy: Access to rural India |
Q35544166 | Telemedicine in diabetic retinopathy: current status and future directions |
Q64977149 | Teleophthalmology Support for Primary Care Diagnosis and Management. |
Q47203189 | Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study |
Q38880569 | Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy |
Q46407140 | Ten years of anti-vascular endothelial growth factor therapy |
Q34408245 | Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. |
Q26748944 | The Adenosinergic System in Diabetic Retinopathy |
Q34545993 | The Association between VDR Gene Polymorphisms and Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis |
Q60907887 | The Association of CEP135 rs4865047 and NPY2R rs1902491 Single Nucleotide Polymorphisms (SNPs) with Rapid Progression of Proliferative Diabetic Retinopathy in Patients with Type 1 Diabetes Mellitus |
Q36044969 | The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012. |
Q64916531 | The Association of Serum Leptin Level and Anthropometric Measures With the Severity of Diabetic Retinopathy in Type 2 Diabetes Mellitus. |
Q49181841 | The Beijing Desheng Diabetic Eye Study: rationale, design, methodology and baseline data. |
Q92538952 | The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells |
Q91966635 | The Detection and Partial Localisation of Heteroplasmic Mutations in the Mitochondrial Genome of Patients with Diabetic Retinopathy |
Q28075888 | The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both? |
Q35902518 | The Effects of Diabetic Retinopathy and Pan-Retinal Photocoagulation on Photoreceptor Cell Function as Assessed by Dark Adaptometry |
Q41171782 | The Effects of the Contact Activation System on Hemorrhage |
Q90409273 | The Evolving Treatment of Diabetic Retinopathy |
Q102060110 | The Lancet Commission on diabetes: using data to transform diabetes care and patient lives |
Q49169179 | The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. |
Q37418776 | The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application. |
Q36245823 | The Prevention and Treatment of Retinal Complications in Diabetes |
Q64285140 | The Role of Adiponectin and Toll-Like Receptor 4 Gene Polymorphisms on Non-Proliferative Retinopathy in Type 2 Diabetes Mellitus Patients. A Case control Study in Romanian Caucasians Patients |
Q48211404 | The Role of Glycemic Control and Variability in Diabetic Retinopathy |
Q37548105 | The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications. |
Q39007482 | The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management |
Q102220279 | The SUSTech-SYSU dataset for automated exudate detection and diabetic retinopathy grading |
Q41229548 | The Status of Maculopathy in Diabetes and Prediabetes Patients in a Population-Based Study Detected by Optical Coherence Tomography: The 2011 Health Examination Survey in Beijing |
Q51430597 | The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown. |
Q64971142 | The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema. |
Q26783404 | The Vitreomacular Interface in Diabetic Retinopathy |
Q91598423 | The War on Diabetic Retinopathy: Where Are We Now? |
Q35301427 | The association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010. |
Q89616540 | The association between eating behavior and polymorphisms in GRIN2B, GRIK3, GRIA1 and GRIN1 genes in people with type 2 diabetes mellitus |
Q40968743 | The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes |
Q37212766 | The association of physical activity and cholesterol concentrations across different combinations of central adiposity and body mass index |
Q38828410 | The changing face of diabetes complications |
Q98727175 | The corneal effects of intravitreal dexamethasone implantation |
Q34615668 | The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial |
Q98237750 | The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis |
Q38150855 | The evolving treatment options for diabetic macular edema |
Q48290530 | The eye as a complement dysregulation hotspot. |
Q38396875 | The genetics of diabetic complications |
Q91892449 | The impact of artificial intelligence in screening for diabetic retinopathy in India |
Q90197758 | The impact of artificial intelligence in the diagnosis and management of glaucoma |
Q35048504 | The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia |
Q35618267 | The prevalence of and major risk factors associated with diabetic retinopathy in Gegharkunik province of Armenia: cross-sectional study. |
Q38692341 | The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future. |
Q92621182 | The profile of sight-threatening diabetic retinopathy in patients attending a specialist eye clinic in Hangzhou, China |
Q95933519 | The purchase of the Diabetic Healthy Food Basket in Cyprus results in cost savings: is it affordable among the low-income population? |
Q94585827 | The relationship between carotid disease and retinopathy in diabetes: a systematic review |
Q47731172 | The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes. |
Q33683197 | The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy |
Q36744879 | The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients |
Q58784813 | The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy |
Q92025135 | The role of steroids in treating diabetic macular oedema in the era of anti-VEGF |
Q36461851 | The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package |
Q90575860 | The use of optical coherence tomography angiography and optical coherence tomography to predict visual acuity in diabetic retinopathy |
Q30394609 | The worldwide epidemic of diabetic retinopathy. |
Q92120247 | Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study |
Q38873909 | Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy |
Q50049076 | Therapeutic targets for altering mitochondrial dysfunction associated with diabetic retinopathy. |
Q53097624 | Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema. |
Q36612276 | Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint |
Q60300737 | Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab |
Q31005299 | Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications |
Q91805508 | Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke |
Q64106481 | Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development |
Q104070104 | Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study |
Q30235021 | Type 1 diabetes mellitus |
Q35711668 | Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping |
Q89844956 | U.S. county "food swamp" severity and hospitalization rates among adults with diabetes: A nonlinear relationship |
Q64107754 | Unfolded Protein Response Pathways Correlatively Modulate Endoplasmic Reticulum Stress Responses in Rat Retinal Müller Cells |
Q37406852 | United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. |
Q38285522 | Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases. |
Q39427264 | Update on Diagnosis and Treatment of Diabetic Retinopathy: A Consensus Guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society). |
Q92319046 | Update on Screening for Sight-Threatening Diabetic Retinopathy |
Q26773225 | Update on genetics and diabetic retinopathy |
Q36298105 | Update on wide- and ultra-widefield retinal imaging |
Q53421840 | Urban-rural differences in the prevalence of diabetes mellitus among 25-74 year-old adults of the Yangon Region, Myanmar: two cross-sectional studies. |
Q38719213 | Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice |
Q92860697 | Ursodeoxycholic Acid Attenuates the Retinal Vascular Abnormalities in Anti-PDGFR-β Antibody-Induced Pericyte Depletion Mouse Models |
Q38949051 | Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind |
Q35884438 | Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting |
Q36885757 | Usefulness of Discarded Vitreous Samples from Routine Vitrectomy |
Q35075399 | Using Markov Chains to predict the natural progression of diabetic retinopathy |
Q47311711 | Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System |
Q92125814 | Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat |
Q55091488 | Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy. |
Q36266894 | Virtual screening of RAGE inhibitors using molecular docking |
Q36537266 | Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy |
Q38773655 | Vitamin D and diabetes mellitus: Causal or casual association? |
Q52571010 | Vitamin D3 Protects against Diabetic Retinopathy by Inhibiting High-Glucose-Induced Activation of the ROS/TXNIP/NLRP3 Inflammasome Pathway. |
Q92623020 | Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema |
Q38293676 | Vitreous humor in the pathologic scope: insights from proteomic approaches. |
Q55007680 | Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment. |
Q36182391 | White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging |
Q35745813 | Wide-Field Megahertz OCT Imaging of Patients with Diabetic Retinopathy. |
Q64084236 | Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis |
Q36049918 | Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti-inflammatory and antiangiogenic mechanisms |
Q49808386 | [Expression of VEGF and PEDF in early-stage retinopathy in diabetic Macaca mulatta]. |
Q92168513 | [Prevalence and risk factors associated with diabetic retinopathy in Santander. Northern Spain] |
Q90394480 | circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications |
Q89017438 | iT2DMS: a Standard-Based Diabetic Disease Data Repository and its Pilot Experiment on Diabetic Retinopathy Phenotyping and Examination Results Integration |
Q47116645 | miRNA-1273g-3p Involvement in Development of Diabetic Retinopathy by Modulating the Autophagy-Lysosome Pathway. |
Q54978588 | miR‑133b regulates proliferation and apoptosis in high‑glucose‑induced human retinal endothelial cells by targeting ras homolog family member A. |
Q48096036 | p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy. |
Search more.